[1] |
HUANG Hao, LIANG Jingjing, TAO Yifeng, PAN Xiaolan, FANG Min.
Analysis of hepatitis B virus serum markers in 92,031 cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 101-106.
|
[2] |
HUANG Qing, ZHEN Lan, ZHAO Guilin, ZHAO Ruzhou, YE Xinping, WU Feixiang.
Construction and identification of macrophage-conditional GP73 gene knockout mice
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 630-636.
|
[3] |
WU Longjunyu, YE Chunhua, YAO Qingchun, LI Yuandong, ZHANG Chunyan.
Application values of two dicarboxyl acylcarnitines in hepatitis B virus related diseases based on targeted metabolomics
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 202-207.
|
[4] |
ZHAN Shicheng, CHEN Peiqin, QIU Moqin, WEN Qiuping, ZHOU Zihan, LIN Qiuling, JIANG Yanji, ZHOU Xianguo, CAO Ji, GUO Qian, NONG Cunli, YU Hongping, LIU Yingchun.
Association of genetic variants in eukaryotic translation initiation factor 3 and risk of HBV⁃related hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(1): 62-69.
|
[5] |
LI Hong, WU Linghong, DENG Wei, HUANG Youquan, HAN Xiao, LIAN Shanxiong, HUANG Tianren.
Analysis of HBV S gene mutation in HBV-related hepatocellular carcinoma tissues and pericarcinoma liver tissues in Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 382-386.
|
[6] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|
[7] |
Fan Ni,Lu Yuxiu,Tang Yanping,Li Kezhi,He Pan,Cao Ji,Lu Yulei, Lin Youzhi, Yang Chun.
Detecting changes in TLR-4 and IL-6 during hepatitis B virus infection in a tree shrew model
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 95-99.
|
[8] |
Zhang Zhi,Guo Peng,Sun Xing,Xiao Yi,Xu Jing,Peng Tao,Zhao Guoliang,Wu Shuyue,Huang Hai.
Effects of hepatitis B virus X gene on expression of HSF1 and growth in HepG2 human hepatoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(4): 306-310.
|
[9] |
Gan Yingyuan,Deng Wei,Huang Tianren,Wu Hanghang,Huang Yueying,Zhang Yuli.
A case-control study of association between hepatitis B virus S gene mutation and primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(3): 181-185.
|
[10] |
Wu Hanghang,Huang Tianren,Deng Wei,Fang Xiang,Ren Jingjing,Gan Yingyuan.
Analysis of hepatitis B virus X gene integration and potential risk factors of integration in patients with hepatocellular carcinoma in the high-incidence area of Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(3): 172-176.
|
[11] |
Ren Jingjing,Deng Wei,Fang Xiang,Xiao Chanchan,Wu Hanghang.
Comparison of next-generation sequencing and clone-based sequencing for analysis of X gene mutation sites in hepatitis B virus quasispecies
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 133-138.
|
[12] |
Li Kezhi,Deng Wei,Li Yunxi,Li Jilin,Zhang Chunyan,Ren Jingjing,Wu Hanghang.
Microcystin content of different water sources in a region of Guangxi showing high incidence of liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 387-390.
|
[13] |
Jia Shouwei,Shao Qiong,Wu Xiaoyan,Cao Li,Long Zijun,Shao Jianyong,Huang Hongbing.
Anaplastic lymphoma kinase gene expression and its clinical significance in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 354-359.
|
[14] |
Ren Ai'hua,Liao Yan,Wei Liujun,Zhao Ruiqiang,Wei Feifei,Xie Yu'an.
DDX39 single-nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma in clusters of families with liver cancer in Fusui County, Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 344-348.
|
[15] |
Bai,Qi Lunan,Chen Jie,Ye Jiazhou,Wu Feixiang,Peng Tao,Li Lequn.
Significance of p53 gene mutation and expression in human primary hepatocellular carcinoma in the presence of hepatitis B virus and aflatoxin B1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(1): 1-6.
|